From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)
Time
Group A
Group B
A/B#
Death
19 (60.0%)
26 (80.0%)
0.168
